A drug recall has been issued for aripiprazole bottles mistakenly containing an antifungal medication instead. This mix-up, involving more than 6,000 bottles, poses serious risks to patients with mental health conditions. The FDA classified this as a Class II recall, indicating the wrong drug could cause temporary health effects. A similar mix-up involved an ADHD medication being recalled in 2024 for the same type of labeling error. Patients are urged to check bottle labels and report any adverse reactions to the FDA immediately. The scene is disturbingly familiar: another pharmaceutical company, another recall, another chance for consumers to wonder exactly…

Newswire

Features

The Latest